Skip to main content
Terug
Watch Compare

Instil Bio, Inc.

Datakwaliteit: 83%
TIL
Nasdaq Manufacturing Chemicals
€ 8,35
▼ € 0,19 (-2,22%)
Marktkapitalisatie: 56,63 M
Prijs
€ 8,35
Marktkapitalisatie
56,63 M
Dagbereik
€ 8,17 — € 8,47
52-Weeksbereik
€ 5,67 — € 42,79
Volume
7.809
Openen € 8,24
50D / 200D Gem.
€ 8,21
1,70% above
50D / 200D Gem.
€ 16,49
49,36% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -36,62 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-56,62%
Onder sectorgemiddelde (-51,02%)
ROIC-29,34%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio34,45
Interest Coverage-13,48

Waardering

PE (TTM)
-0,79
Boven sectorgemiddelde (-1,98)
P/B Ratio0,47
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -2,0
P/B 0,5 5,1
ROE % -56,6 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -71,37 M
ROE -56,62% ROA -32,24%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -36,62 M
ROIC -29,34% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 34,45
Interest Coverage -13,48 Asset Turnover N/A
Working Capital 190,57 M Tangible Book Value 120,42 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,79 Forward P/E N/A
P/B Ratio 0,47 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -64,66%
Market Cap 56,63 M Enterprise Value 50,83 M
Per Share
EPS (Diluted TTM) -10,70 Revenue / Share N/A
FCF / Share -5,40 OCF / Share -5,40
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 51,31%
SBC-Adj. FCF -47,77 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0,0
Net Income -71,37 M -74,14 M -156,09 M -223,18 M -156,79 M
EPS (Diluted) -10,70 -11,39 -24,00 -1,72 -1,48
Gross Profit — — — — —
Operating Income -78,58 M -73,54 M -159,17 M -226,46 M -155,56 M
EBITDA — — — — —
R&D Expenses — — 39,60 M 141,06 M 107,25 M
SG&A Expenses — — — — —
D&A 534.000,0 3,61 M 4,76 M 5,99 M 2,75 M
Interest Expense 5,83 M 8,99 M 5,21 M 1,88 M —
Income Tax 0,0 — 0,0 -2,07 M 39.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 203,52 M 263,57 M 325,63 M 482,13 M 609,98 M
Total Liabilities 89,66 M 94,13 M 99,80 M 118,52 M 54,78 M
Shareholders' Equity 113,87 M 169,44 M 225,83 M 363,61 M 555,20 M
Total Debt — — — — —
Cash & Equivalents 6,64 M 8,81 M 9,20 M 43,72 M 37,59 M
Current Assets 191,43 M 124,47 M 160,76 M 269,38 M 464,02 M
Current Liabilities 4,84 M 7,90 M 10,56 M 32,79 M 41,36 M